retatrutide clinical trials status 2025 HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III TRIALS⛔️ Retatrutide is not currently FDA-approved, as it is in Phase III clinical with anticipated completion in 2025–2026 and The retatrutide drug is manufactured

Nasal Spray Melanotan 2 Nasal Spray Synthetic alpha-MSH analog nasal spray, 6mg total, 80 sprays at 75mcg per spray

The complaint alleges several instances when Fella Healths non-physician personnel advised patients on medication doses and side effects and implied that they could adjust patient prescriptions, without mentioning the need for medical input

Retatrutide adds glucagon receptor activation on top of the GLP-1 and GIP effects

Hyaluronic acid Although not a collagen precursor, oral hyaluronic acid has been studied for its potential to support skin hydration and elasticity and is frequently combined with collagen ingredients